These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8986746)

  • 21. Recombinant human gamma interferon inhibits simian malaria.
    Maheshwari RK; Czarniecki CW; Dutta GP; Puri SK; Dhawan BN; Friedman RM
    Infect Immun; 1986 Sep; 53(3):628-30. PubMed ID: 3091507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mycobacterium-induced potentiation of type 1 immune responses and protection against malaria are host specific.
    Page KR; Jedlicka AE; Fakheri B; Noland GS; Kesavan AK; Scott AL; Kumar N; Manabe YC
    Infect Immun; 2005 Dec; 73(12):8369-80. PubMed ID: 16299335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
    Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
    Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of WR250417 (a proguanil analog) for causal prophylactic activity in the Plasmodium cynomolgi-Macaca mulatta model.
    Edstein MD; Corcoran KD; Shanks GD; Ngampochjana M; Hansukjariya P; Sattabongkot J; Webster HK; Rieckmann KH
    Am J Trop Med Hyg; 1994 Feb; 50(2):181-6. PubMed ID: 8116810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential role of T regulatory and Th17 in Swiss mice infected with Plasmodium berghei ANKA and Plasmodium yoelii.
    Keswani T; Bhattacharyya A
    Exp Parasitol; 2014 Jun; 141():82-92. PubMed ID: 24675415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA prime-protein boost immunization in monkeys: efficacy of a novel construct containing functional domains of Plasmodium cynomolgi CS and TRAP.
    Bhardwaj D; Kushwaha A; Puri SK; Herrera A; Singh N; Chauhan VS
    FEMS Immunol Med Microbiol; 2003 Dec; 39(3):241-50. PubMed ID: 14642309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of interferon in malaria infection.
    Maheshwari RK; Srikantan V; Bhartiya D; Puri SK; Dutta GP; Dhawan BN
    Immunol Lett; 1990 Aug; 25(1-3):53-7. PubMed ID: 2126528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Causal prophylactic and radical curative activity of WR182393 (a guanylhydrazone) against Plasmodium cynomolgi in Macaca mulatta.
    Corcoran KD; Hansukjariya P; Sattabongkot J; Ngampochjana M; Edstein MD; Smith CD; Shanks GD; Milhous WK
    Am J Trop Med Hyg; 1993 Oct; 49(4):473-7. PubMed ID: 8214277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of antimalaria immunity in mice lacking IFN-gamma receptor.
    Tsuji M; Miyahira Y; Nussenzweig RS; Aguet M; Reichel M; Zavala F
    J Immunol; 1995 May; 154(10):5338-44. PubMed ID: 7537305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics and pharmacodynamics of subcutaneous injection and intravenous infusion of recombinant human interleukin-12 and recombinant human interleukin-12 combined with hepatitis B surface antigen in cynomolgus monkeys.
    Li R; Deng F; Fu Y; Zhang Y; Wan H; Zhou D; Gu J; Xu J
    Pharmacology; 2010; 85(6):319-27. PubMed ID: 20516733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Observations on the exoerythrocytic stages of different isolates of Plasmodium cynomolgi in hepatocytes of New World aotus and Saimiri monkeys.
    Sullivan JS; Stewart A; Bounngaseng A; Sullivan JJ; Nace D; Williams A; Galland GG; Williams T; Henry F; Collins WE
    J Parasitol; 2006 Feb; 92(1):202-5. PubMed ID: 16629341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytokine production in rhesus monkeys infected with Plasmodium coatneyi.
    Yang C; Xiao L; Tongren JE; Sullivan J; Lal AA; Collins WE
    Am J Trop Med Hyg; 1999 Aug; 61(2):226-9. PubMed ID: 10463671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nanoparticle formulation enhanced protective immunity provoked by PYGPI8p-transamidase related protein (PyTAM) DNA vaccine in Plasmodium yoelii malaria model.
    Cherif MS; Shuaibu MN; Kodama Y; Kurosaki T; Helegbe GK; Kikuchi M; Ichinose A; Yanagi T; Sasaki H; Yui K; Tien NH; Karbwang J; Hirayama K
    Vaccine; 2014 Apr; 32(17):1998-2006. PubMed ID: 24440206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytokines kill malaria parasites during infection crisis: extracellular complementary factors are essential.
    Naotunne TS; Karunaweera ND; Del Giudice G; Kularatne MU; Grau GE; Carter R; Mendis KN
    J Exp Med; 1991 Mar; 173(3):523-9. PubMed ID: 1900073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase I study of the sequential combination of interleukin-12 and interferon alfa-2b in advanced cancer: evidence for modulation of interferon signaling pathways by interleukin-12.
    Eisenbeis CF; Lesinski GB; Anghelina M; Parihar R; Valentino D; Liu J; Nadella P; Sundaram P; Young DC; Sznol M; Walker MJ; Carson WE
    J Clin Oncol; 2005 Dec; 23(34):8835-44. PubMed ID: 16314644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Down-regulation of the pharmacokinetic-pharmacodynamic response to interleukin-12 during long-term administration to patients with renal cell carcinoma and evaluation of the mechanism of this "adaptive response" in mice.
    Rakhit A; Yeon MM; Ferrante J; Fettner S; Nadeau R; Motzer R; Bukowski R; Carvajal DM; Wilkinson VL; Presky DH; Magram J; Gately MK
    Clin Pharmacol Ther; 1999 Jun; 65(6):615-29. PubMed ID: 10391667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics and immunological aspects of a phase Ib study with intratumoral administration of recombinant human interleukin-12 in patients with head and neck squamous cell carcinoma: a decrease of T-bet in peripheral blood mononuclear cells.
    Van Herpen CM; Huijbens R; Looman M; De Vries J; Marres H; Van De Ven J; Hermsen R; Adema GJ; De Mulder PH
    Clin Cancer Res; 2003 Aug; 9(8):2950-6. PubMed ID: 12912941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for strain-specific protective immunity against blood-stage parasites of Plasmodium cynomolgi in toque monkey.
    Wijayalath WA; Cheesman S; Rajakaruna J; Handunnetti SM; Carter R; Pathirana PP
    Parasite Immunol; 2008; 30(11-12):630-6. PubMed ID: 19067844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential expression of cytokine genes among sickle-cell-trait (HbAS) and normal (HbAA) children infected with Plasmodium falciparum.
    Hassan DA; Marques C; Santos-Gomes GM; do Rosario VE; Mohamed HS; Elhussein AM; Ibrahim ME; Abdulhadi NH
    Ann Trop Med Parasitol; 2009 Jun; 103(4):283-95. PubMed ID: 19508746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New adamantane-based spiro 1,2,4-trioxanes orally effective against rodent and simian malaria.
    Singh C; Kanchan R; Sharma U; Puri SK
    J Med Chem; 2007 Feb; 50(3):521-7. PubMed ID: 17266204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.